Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Genenta Science S.p.A. - American Depositary Shares
(NQ:
GNTA
)
3.177
-0.033 (-1.03%)
Streaming Delayed Price
Updated: 1:06 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,218
Open
3.170
Bid (Size)
1.360 (1)
Ask (Size)
5.370 (2)
Prev. Close
3.210
Today's Range
3.170 - 3.380
52wk Range
2.560 - 6.120
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 02, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 01, 2025
Via
Benzinga
Performance
YTD
-29.9%
-29.9%
1 Month
+4.5%
+4.5%
3 Month
-15.2%
-15.2%
6 Month
-17.9%
-17.9%
1 Year
-42.2%
-42.2%
More News
Read More
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
July 01, 2025
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
May 07, 2025
From
GENENTA SCIENCE SPA; Anemocyte
Via
GlobeNewswire
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
April 15, 2025
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
March 19, 2025
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
January 09, 2025
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
October 23, 2024
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 10, 2024
Via
Benzinga
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
October 02, 2024
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
Via
InvestorPlace
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 36th Annual Roth Conference
March 01, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
February 12, 2024
Via
Benzinga
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
February 08, 2024
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 22, 2023
Via
Benzinga
Genenta to Present at Upcoming Scientific and Investor Conferences
September 06, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
July 28, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
June 29, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta to Provide Update on Lead Product Temferon™
May 16, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
April 26, 2023
From
GENENTA SCIENCE SPA
Via
GlobeNewswire
Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 35th Annual Roth Conference
February 22, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Frequently Asked Questions
Is Genenta Science S.p.A. - American Depositary Shares publicly traded?
Yes, Genenta Science S.p.A. - American Depositary Shares is publicly traded.
What exchange does Genenta Science S.p.A. - American Depositary Shares trade on?
Genenta Science S.p.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Genenta Science S.p.A. - American Depositary Shares?
The ticker symbol for Genenta Science S.p.A. - American Depositary Shares is GNTA on the Nasdaq Stock Market
What is the current price of Genenta Science S.p.A. - American Depositary Shares?
The current price of Genenta Science S.p.A. - American Depositary Shares is 3.177
When was Genenta Science S.p.A. - American Depositary Shares last traded?
The last trade of Genenta Science S.p.A. - American Depositary Shares was at 10/17/25 01:06 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.